Funder
Department of Science and Technology, Ministry of Science and Technology
Science and Engineering Research Board
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science
Reference134 articles.
1. Culen M, Dohnal J. Advances in dissolution instrumentation and their practical applications. Drug Dev Ind Pharm. 2014;40(10):1277–82.
https://doi.org/10.3109/03639045.2013.841184
.
2. USFDA. Guidance for industry: waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. In: U.S. Department of Health and Human Services FaDA, Center for Drug Evaluation and Research (CDER), editor. 2017.
3. Patadia R, Vora C, Mittal K, Mashru R. Dissolution criticality in developing solid oral formulations: from inception to perception. Crit Rev Ther Drug Carrier Syst. 2013;30(6):495–534.
4. USFDA. Guidance for industry; immediate release solid oral dosage forms: scale-up and postapproval changes: chemistry, manufacturing, and controls, in vitro dissolution testing, and in vivo bioequivalence documentation. In: U.S. Department of Health and Human Services FaDA, Center for Drug Evaluation and Research (CDER), editor. 1995.
5. Grignard E, Taylor R, McAllister M, Box K, Fotaki N. Considerations for the development of in vitro dissolution tests to reduce or replace preclinical oral absorption studies. Eur J Pharm Sci. 2017;99:193–201.
https://doi.org/10.1016/j.ejps.2016.12.004
.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献